Author Archives: Michelle Johnston-Fleece

Clinical pathways in cancer care

The number of cancer survivors in the United States continues to increase. Concurrently, the focus of the U.S. health care system is shifting towards the value of care patients receive. To us in the cancer community, this means focusing on … Continue reading

Posted in Cancer Policy Institute | Leave a comment

Americans left behind by health reform

In order to expand access to health care to all Americans, the Affordable Care Act (ACA) attempted to expand Medicaid eligibility in all U.S. states.  The federal government is obligated to pay 100% of the cost of the Medicaid expansion … Continue reading

Posted in Cancer Advocacy, Cancer Policy Institute | Leave a comment

The Federal Government shutdown’s impact on people with cancer

On Tuesday, October 1, the federal government began a partial shutdown after Congress became gridlocked over funding for the government and its activities for the new budget year (which started that day). As we noted then, the shutdown does not … Continue reading

Posted in Cancer Policy Institute | Tagged , , , , | Leave a comment

Health insurance marketplaces open for business

As we have discussed, today is the day that the Health Insurance Marketplaces open so that consumers can compare plans and shop for affordable insurance coverage. The Marketplaces will make health insurance coverage available to the 48 million Americans who are … Continue reading

Posted in Cancer Advocacy, Cancer Education, Cancer Policy Institute, Cancer Support, Living with Cancer | Leave a comment

The Cancer Insurance Checklist: Your guide to shopping for insurance on the marketplace/exchange

As implementation of the health reform law (the Affordable Care Act) continues, individuals that do not have insurance through an employer or government plan like Medicare or Medicaid will be required to purchase insurance on state-based Health Insurance Marketplaces, or … Continue reading

Posted in Cancer Policy Institute | Tagged , , , , , | Leave a comment